Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H21NO3 |
Molecular Weight | 287.3535 |
Optical Activity | ( + ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](O)C=C[C@@]13CCN(C)CC4=CC=C(OC)C(O2)=C34
InChI
InChIKey=ASUTZQLVASHGKV-SUYBPPKGSA-N
InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24315193Curator's Comment: description was created based on several sources, including
https://www.heterocycles.jp/newlibrary/libraries/abst/08228 | https://www.ncbi.nlm.nih.gov/pubmed/27505136
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24315193
Curator's Comment: description was created based on several sources, including
https://www.heterocycles.jp/newlibrary/libraries/abst/08228 | https://www.ncbi.nlm.nih.gov/pubmed/27505136
(+)-Galanthamine is an alkaloid benzazepine derived from norbelladine. In contrast to the (-)-Galanthamine, (+)-Galanthamine demonstrates substantially lower biological activity.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24315193 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24315193
(+)-[11C]galanthamine (3.7 MBq) was administered to seven-week-old male ddY mice. Five animals were then sacrificed by exsanguination at time-points of 2, 5, 15, 30, and 60 min post-administration
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24315193
The inhibitory activities of (+)-galanthamine against AChE were measured using a modified version of the colorimetric method of Ellman. 2 mkL of a 10-mM solution of (+)-Galanthamine in 0.1 M phosphate buffer (pH 8) was mixed with 190 mkL of AChE solution (extracted from the brain tissue of a 9-week-old rat) in each well of a 96-well titer plate. After the incubation of the titer plate for 30 min at 37 C, 600 mkL of 10-mM 5,50-dithiobis-(2-nitrobenzoic acid) (DTNB), 100 mkL of 150 mM acetylthiocholine iodide and 100 mkL of buffer were successively added. Changes in UV absorbance of the reaction mixture were then measured at 2 min intervals in a 96-well plate reader at 415 nm, three times, consecutively.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
60384-53-4
Created by
admin on Sat Dec 16 05:41:44 GMT 2023 , Edited by admin on Sat Dec 16 05:41:44 GMT 2023
|
PRIMARY | |||
|
906210
Created by
admin on Sat Dec 16 05:41:44 GMT 2023 , Edited by admin on Sat Dec 16 05:41:44 GMT 2023
|
PRIMARY | |||
|
8L3T05AQ82
Created by
admin on Sat Dec 16 05:41:44 GMT 2023 , Edited by admin on Sat Dec 16 05:41:44 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD